Niki BioSolutions, Inc. (NIKI) income statement
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.57−0.11 (-6.55%)
Close on Nov 20, 2026Market cap $12.79MP/E –Yield –
Niki BioSolutions, Inc. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -6.2%
Financial strength
- Current ratio
- 0.78
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 75.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.55
- Dividend yield
- –
See a number that looks wrong?